Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Debut trading of Kinnate Biopharma, Inc.

04.12.2020

In their debut trading on Thursday December 3, 2020 Kinnate Biopharma, Inc (KNTE) showed a 95.15% increase and closed at $39.03 per share. Shortly before the company had placed its shares  in an IPO priced $20 per share.